慢性肾病患者袖状胃切除与胃旁路术围术期风险比较
该研究基于MBSAQIP数据库,将2015-2017年接受Roux-en-Y胃旁路术(RYGB)或袖状胃切除术的慢性肾病(CKD)患者按1:1倾向评分匹配,比较30天再入院、手术并发症、内科并发症和死亡。结果显示两组主要结局无显著差异,仅急性肾损伤在RYGB组更高(4.9% vs 2.7%,P=0.035,E值1.27),但E值较小提示该差异易受未测量混杂影响。
要点
- CKD患者行RYGB与袖状胃切除的30天主要围术期结局无显著差异。
- RYGB组急性肾损伤发生率显著更高(4.9% vs 2.7%,P=0.035),但E值仅1.27。
- 认为RYGB在CKD患者中围术期风险过高的观点值得商榷,术式选择应基于候选资格和预期长期获益。
核心结论
- 在匹配良好的CKD患者中,RYGB与袖状胃切除的主要围术期结局发生率相似。
- 仅急性肾损伤在RYGB组显著更高,但E值较小,相对较弱的混杂因素即可消除该差异。
- RYGB在CKD患者中围术期风险过高的观念存在争议,术式选择应权衡患者候选资格与预期长期获益。
研究设计与样本
- 回顾性队列研究,使用MBSAQIP Participant Use File数据。
- 纳入2015-2017年接受RYGB或袖状胃切除的CKD患者。
- RYGB患者按1:1倾向评分匹配袖状胃切除患者,匹配因素为影响术式选择的术前因素。
- 最终RYGB组n=673,袖状胃切除组n=673。
- 采用单因素逻辑回归比较结局,并用E值统计量检验未测量混杂的强度。
主要发现
- 两组人口学特征相似。
- 主要结局(30天再入院、手术并发症、内科并发症、死亡)无统计学显著差异。
- 次要结局中,仅急性肾损伤在RYGB组显著更高(4.9% vs 2.7%,P=0.035,E值1.27)。
关键数值与推荐
- 主要结局包括30天再入院、手术并发症、内科并发症和死亡。
- 次要结局包括构成复合手术/内科并发症的各个并发症。
- 急性肾损伤发生率RYGB组4.9%,袖状胃切除组2.7%,P=0.035,E值1.27。
临床怎么用
- CKD患者选择RYGB时,不应仅因 perceived 围术期风险过高而排除,需综合评估候选资格和长期获益。
- 术后应关注RYGB组急性肾损伤风险,但需认识到该差异证据强度较弱。
局限性
- E值较小,提示急性肾损伤的差异可能受未测量混杂因素影响。
- 研究为回顾性数据库分析,可能存在选择偏倚和混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether patients with CKD experience higher rates of perioperative complications after RYGB compared to sleeve gastrectomy. SUMMARY OF BACKGROUND DATA: For obese CKD patients who qualify for bariatric surgery, sleeve gastrectomy is often preferred to RYGB based on perceptions of prohibitively-high perioperative risks surrounding RYGB. However, some patients with CKD are not candidates for sleeve gastrectomy and the incremental increased-risk from RYGB has never been rigorously tested in this population. METHODS: CKD patients who underwent RYGB or sleeve gastrectomy between 2015 and 2017 were identified from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program Participant Use File. RYGB patients were 1:1 propensity-score matched with sleeve gastrectomy patients based on preoperative factors that influence operative choice. Primary outcomes included 30-day readmissions, surgical complications, medical complications, and death. Secondary outcomes included the individual complications used to create the composite surgical/medical complications. Univariate logistic regression was used to compare outcomes. E-value statistic was used to test the strength of outcome point estimates against possible unmeasured confounding. RESULTS: Demographics were similar between RYGB (n = 673) and sleeve gastrectomy (n = 673) cohorts. There were no statistically significant differences in primary outcomes. Among secondary outcomes, only acute kidney injury was statistically-significantly higher among RYGB patients (4.9% vs 2.7%, P = 0.035, E-value 1.27). CONCLUSIONS: Among well-matched cohorts of RYGB and sleeve gastrectomy patients, incidence of primary outcomes were similar. Among secondary outcomes, only acute kidney injury was statistically-significantly higher among RYGB patients; however, the E-value for this difference was small and relatively weak confounder(s) could abrogate the statistical difference. The perception that RYGB has prohibitively-high perioperative risks among CKD patients is disputable and operative selection should be weighed on patient candidacy and anticipated long-term benefit.
引用
- Montgomery JR, Waits SA, Dimick JB, et al. Perioperative Risks of Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass Among Patients With Chronic Kidney Disease: A Review of the MBSAQIP Database. Ann Surg. 2021. PMID: 31599806. doi:10.1097/SLA.0000000000003627
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。